Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility

Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2*

(2015) Jeam Haroldo Oliveira Barbosa et al.   MAGNETIC RESONANCE IMAGING

A multicontrast approach for comprehensive imaging of substantia nigra

(2015) Jason Langley et al.   NEUROIMAGE

Longitudinal midbrain changes in early Parkinson's disease: Iron content estimated from R2*/MRI

(2015) Marguerite Wieler et al.   PARKINSONISM & RELATED DISORDERS

Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

(2013) David Devos et al.   ANTIOXIDANTS & REDOX SIGNALING

Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD

(2013) C. Loane et al.   NEUROLOGY

Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease

(2013) Nico Bunzeck et al.   PARKINSONISM & RELATED DISORDERS

Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up

(2013) Miguel Ulla et al.   PLoS One

Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease

(2012) L. Jin et al.   EUROPEAN JOURNAL OF NEUROLOGY

Different Iron-Deposition Patterns of Multiple System Atrophy with Predominant Parkinsonism and Idiopathetic Parkinson Diseases Demonstrated by Phase-Corrected Susceptibility-Weighted Imaging

(2011) Y. Wang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease

(2011) Stefan T. Schwarz et al.   MOVEMENT DISORDERS

Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study

(2010) Jiuquan Zhang et al.   BRAIN RESEARCH

Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence

(2010) Karla Hopp et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults

(2010) E. Mark Haacke et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration

(2010) David T. Dexter et al.   JOURNAL OF NEURAL TRANSMISSION

MRI estimates of brain iron concentration in normal aging: Comparison of field-dependent (FDRI) and phase (SWI) methods

(2009) Adolf Pfefferbaum et al.   NEUROIMAGE

Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1

(2008) E.M. Haacke et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

MRI assessment of basal ganglia iron deposition in Parkinson's disease

(2008) Lauren I. Wallis et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Midbrain iron content in early Parkinson disease: A potential biomarker of disease status

(2008) W. R. W. Martin et al.   NEUROLOGY

Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications

(2008) Makoto Sasaki et al.   NEUROREPORT